Enobia Reports Positive Results for Phase II Trial of ENB-0040 in Juvenile Hypophosphatasia
Posted on 24. Sep, 2010 in Portfolio News
Enobia Pharma is a portfolio company of Lothian Partners. Kirchner Investment Management Corporation is the manager of Lothian Partners. Prague, Czech Republic 24 September 2010 – Enobia Pharma today announced positive results for its Phase II juvenile clinical trial of ENB-0040 (asfotase alfa), an experimental bone-targeted enzyme replacement therapy intended for the treatment of hypophosphatasia (HPP).
[more]
Toon Boom Unveils Studio 6
Posted on 23. Sep, 2010 in Portfolio News
Toon Boom Animation Inc. is a portfolio company of Lothian Partners. Kirchner Investment Management Corporation is the manager of Lothian Partners. Montreal, Quebec 23 September 23 2010 – Emmy Award-winning Toon Boom Animation Inc. today announced the release of Toon Boom Studio 6, a new version that expands its animation capabilities even further with its bone
[more]
Monsanto and AgraQuest to Collaborate on Development of New Seed Treatments
Posted on 13. Sep, 2010 in Portfolio News
AgraQuest is a portfolio company of Foragen Technologies Management Inc. Kirchner Investment Management Corporation is a general partner of Foragen Technologies Management Inc. 13 September 2010 – Monsanto and AgraQuest to Collaborate on Development of New Seed Treatments
Chromatin, Inc. Announces Extension of Syngenta
Posted on 12. Sep, 2010 in Portfolio News
Chromatin, Inc. is a portfolio company of Foragen Technologies Management Inc. Kirchner Investment Management Corporation is a general partner of Foragen Technologies Management Inc. 12 September 2010 – Chromatin, Inc. Announces Extension of Syngenta
Team of Experts Releases Guidance on Safe Deployment of Transgenic Sorghum re: Chromatin
Posted on 09. Sep, 2010 in Portfolio News
Chromatin, Inc. is a portfolio company of Foragen Technologies Management Inc. Kirchner Investment Management Corporation is a general partner of Foragen Technologies Management Inc. 9 September 2010 – Team of Experts Releases Guidance on Safe Deployment of Transgenic Sorghum re: Chromatin
Dave Guebert Joins Advitech’s Board Of Directors
Posted on 08. Sep, 2010 in Portfolio News
Advitech Inc. is a portfolio company of Avrio Ventures. Kirchner Investment Management Corporation is a general partner of Avrio Ventures. Quebec City, Quebec 8 September 2010 – Advitech Inc. (TSX-V: AVI) (“Advitech”) is pleased to announce that Mr. David D. Guebert, CA, CPA has been appointed to its Board of Directors. Mr. Guebert replaces Mr.
[more]
Avrio Ventures Reinvests in Manitoba Harvest
Posted on 08. Sep, 2010 in Portfolio News
Manitoba Harvest is a portfolio company of Avrio Ventures. Kirchner Investment Management Corporation is a general partner of Avrio Ventures. Winnipeg, Manitoba 8 September 2010 – Manitoba Harvest Hemp Foods & Oils, a global leader in hemp foods, today announced that it has secured an additional working capital investment from Avrio Ventures. One of the
[more]
Wavesat Announces Immediate Availability of Tri-band LTE Ref Design for Handsets and Related Devices
Posted on 02. Aug, 2010 in Portfolio News
Wavesat is a portfolio company of Lothian Partners. Kirchner Investment Management Corporation is the manager of Lothian Partners. San Mateo, California 2 August 2010 – Wavesat Inc., a leading supplier of Broadband Wireless semiconductor solutions, today announced immediate availability of a tri-band LTE reference design that manufacturers can use in the development of handset devices, USB dongles
[more]
Nutrition Business Journal profiles Ascenta’s Pure Check program
Posted on 21. Jul, 2010 in Portfolio News
Ascenta is a portfolio company of Avrio Ventures. Kirchner Investment Management Corporation is a general partner of Avrio Ventures. Dartmouth, Nova Scotia 21 July 2010 – Nutrition Business Journal profiles Ascenta’s Pure Check program
Aegera Therapeutics Reports Survival Data from the Phase 1 Portion of its Phase 1-2 Study of AEG35156 in Combination with Sorafenib in Patients with Advanced Hepatocellular Carcinoma
Posted on 19. Jul, 2010 in Portfolio News
Aegera Therapeutics is a portfolio company of Lothian Partners. Kirchner Investment Management Corporation is the manager of Lothian Partners. Montreal, Quebec and Hong Kong, China, 19 July 2010 – Aegera Therapeutics Inc. released today encouraging survival data from the Phase 1 portion of its Phase 1-2 Study of the novel targeted therapeutic, AEG35156, given in combination with sorafenib
[more]